CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 74% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. Please refer to our Risk Disclosure Statement
Gulf Pharmaceutical Industries PSC (ADX: JULPHAR) is one of the Middle East’s leading pharmaceutical manufacturers, dedicated to producing high-quality medicines across multiple therapeutic areas. With a strong presence in regional and global markets, the company plays a critical role in enhancing healthcare accessibility. By investing in research, innovation, and state-of-the-art manufacturing facilities, Gulf Pharmaceutical Industries ensures the development of cutting-edge pharmaceutical solutions. Its commitment to quality and regulatory excellence positions it as a trusted healthcare provider. As the demand for innovative and affordable healthcare solutions rises, Gulf Pharmaceutical Industries continues to expand its product portfolio, supporting medical advancements and public health initiatives.
Nvidia (NVDA) is down approximately 27.37% since the beginning of 2025 (as of mid-April), and up 26.48% year on year – based on its $98.78 open price on 22 April 2025.
The US Tech 100 is down approximately 5.08% year on year (as of late April 2025), and 11.21% year to date, based on its 23 April 2025 opening price of $9,201.47.
10:13, 25 April 2025
Read our reviews to find out more about us1
Read the feedback from our clients, whatever their experience level.
Showing our 4 & 5 star reviews. The specific details of the user have been intentionally anonymised to safeguard their privacy pursuant to GDPR requirements.